BioGaia AB (publ) BioGaia AB (publ)

BioGaia AB (publ)

BIOG-B

Rang in Aktien #8223
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Aktienkurs
$12.59
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$1.24B
Veränderung (1 Tag)
-9.43%
Veränderung (1 Jahr)
10.47%
Land
SE
Handel BioGaia AB (publ) (BIOG-B)

Kategorie

Healthcare
Kursverlauf für BioGaia AB (publ) (BIOG-B)
Höchster Schlusskurs: $12.34 am 2026-10-01

Niedrigster Schlusskurs: $6.50 am 2015-09-01
Kursverlauf der Aktie von BioGaia AB (publ) von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 6.03%
2025 -0.98%
2024 9.23%
2023 17.14%
2022 -25.15%
2021 -12.80%
2020 58.73%
2019 5.53%
2018 53.85%
2016 -32.67%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$161.15 20.52%
DE
$40.45 43.11%
JP
$212.49 24.09%
CH
$7.02 -23.31%
CN